Germline BRCA1and BRCA2 mutations in patients with HER2-negative metastatic breast cancer (mBC) treated with first-line chemotherapy: Data from the German PRAEGNANT registry.
暂无分享,去创建一个
M. Lux | P. Fasching | F. Couch | T. Fehm | A. Schneeweiss | D. Wallwiener | H. Tesch | L. Haeberle | S. Hart | W. Janni | F. Taran | M. Wallwiener | S. Brucker | A. Hartkopf | Chunling Hu | J. Ettl | D. Lüftner | H. Kolberg | F. Overkamp | V. Mueller